Conference preview: Life Science IP Forum, London

In an interview with Legal IQ, which is hosting the Life Science IP Forum on November 27 and 28 in London, Ryan Zurek, managing director of IP merchant bank Ocean Tomo, described the life sciences IP market as “highly inefficient”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

Teva faces scrutiny over efforts to curb generic competition

27 August 2026 Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.

Regulation & Industry

FDA targets faster generic approvals in drive to slash drug prices

27 August 2026 Dozens of new and revised guidances could make it faster and less costly to bring generics to market, as the US ramps up pressure on drug prices.

Biotech

China-origin biotech assets and the hidden question of IP ownership

27 August 2026 As China-origin biotech assets flood the market, licensing deals are booming. Yet, the real strategic battle isn't just about the science—it’s about who controls the underlying IP, says Paul Calvo of Sterne Kessler

More features

Top law firms and individuals recognised in WIPR’s UK Patent Rankings 2026

UK appoints ex-engineer as new intellectual property Minister

Former head of litigation at Nokia returns to Bird & Bird

Novartis scores UK win in high-stakes Entresto fight

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

The UPC plugs another gap in its procedural rulebook

Fran Salisbury: ‘There’s nothing quite like finding the missing piece’

Patent litigator joins Baker Botts in London as UPC grows in significance

Conference preview: Life Science IP Forum, London

More on this story

Editor's picks

Editor's picks

More features